.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Check market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Didanosine - Generic Drug Details

« Back to Dashboard
Didanosine is the generic ingredient in three branded drugs marketed by Aurobindo Pharma, Bristol Myers Squibb, Barr, Aurobindo, and Mylan Pharms Inc, and is included in nine NDAs. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for didanosine. Five suppliers are listed for this compound.

Summary for Generic Name: didanosine

Tradenames:3
Patents:0
Applicants:5
NDAs:9
Drug Master File Entries: see list8
Suppliers / Packagers: see list5
Bulk Api Vendors: see list78
Clinical Trials: see list9
Patent Applications: see list7,230
Therapeutic Class:Antivirals
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:didanosine at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo
DIDANOSINE
didanosine
TABLET, FOR SUSPENSION;ORAL077275-002Aug 14, 2012RXNoNo► subscribe► subscribe
Barr
DIDANOSINE
didanosine
CAPSULE, DELAYED REL PELLETS;ORAL077167-002Dec 3, 2004RXNoNo► subscribe► subscribe
Bristol Myers Squibb
VIDEX EC
didanosine
CAPSULE, DELAYED REL PELLETS;ORAL021183-004Oct 31, 2000RXYesYes► subscribe► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: didanosine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bristol Myers Squibb
VIDEX
didanosine
FOR SOLUTION;ORAL020156-001Oct 9, 19915,616,566*PED► subscribe
Bristol Myers Squibb
VIDEX
didanosine
TABLET, CHEWABLE;ORAL020154-005Oct 9, 19915,254,539*PED► subscribe
Bristol Myers Squibb
VIDEX
didanosine
FOR SOLUTION;ORAL020155-006Oct 9, 19914,861,759*PED► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc